BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28081180)

  • 1. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
    PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.
    Azzi J; Moore RF; Elyaman W; Mounayar M; El Haddad N; Yang S; Jurewicz M; Takakura A; Petrelli A; Fiorina P; Ruckle T; Abdi R
    Diabetes; 2012 Jun; 61(6):1509-18. PubMed ID: 22403300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.
    Comerford I; Litchfield W; Kara E; McColl SR
    PLoS One; 2012; 7(9):e45095. PubMed ID: 23028778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
    Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D
    Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.
    Lacerda-Queiroz N; Brant F; Rodrigues DH; Vago JP; Rachid MA; Sousa LP; Teixeira MM; Teixeira AL
    PLoS One; 2015; 10(3):e0119633. PubMed ID: 25775137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
    Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
    Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
    Holohan DR; Van Gool F; Bluestone JA
    PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
    PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.
    Saito Y; Takeda M; Nishikawa J; Konno Y; Tamaki M; Itoga M; Kobayashi Y; Moritoki Y; Ito W; Chihara J; Ueki S
    Pulm Pharmacol Ther; 2014 Apr; 27(2):164-9. PubMed ID: 24333185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C; Wong FS; Chang CH; Flavell RA
    J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
    Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
    J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response.
    Lupieri A; Smirnova NF; Solinhac R; Malet N; Benamar M; Saoudi A; Santos-Zas I; Zeboudj L; Ait-Oufella H; Hirsch E; Ohayon P; Lhermusier T; Carrié D; Arnal JF; Ramel D; Gayral S; Laffargue M
    Cardiovasc Res; 2020 Feb; 116(2):438-449. PubMed ID: 31106375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
    Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
    J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137
    Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG
    J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.